AMPLY Discovery Limited has raised £900,000 in a mix of equity and grant funding to develop new drug products using its proprietary AI-driven drug discovery platform.  Investors include Co-fund NI, the QUBIS Innovation Fund, the Helix Way Partnership, and Halo Business Angel Network (HBAN).

The Belfast-based biotech company, which is a spin-out from the Queen’s University Belfast, was established in 2021 to commercialise an innovative drug discovery platform which was developed by researchers in the School of Biological Science at Queen’s. Its technology platform has been the subject of more than eight years of scientific research.